NUTX — Nutex Health, Inc. stock price, charts and financials

NASDAQ·Healthcare·Medical - Care Facilities·USA

Latest market price

208.79

-5.53-2.58%

Overview Short InterestFilings

NUTXQT92Nutex Health, Inc.·NASDAQ

Overview Short InterestFilings

208.79-2.58%

News

Down 2.6% — Nutex Health Q2 2026 Earnings Call: Complete Transcript (Benzinga).

Medium confidence

Loading chart...

Signal & projected range

Insider open-market saleHistorical pattern — not a prediction

Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)

Horizon

Unlock the projected rangeSee where this setup landed historically — with Premium.

Unlock with Premium

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Unlock with Premium to see the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands of historical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →

HCSG-0.09%$21.47 INNV+2.06%$10.92 AGL-0.01%$89.16 PNTG-1.02%$39.62 ARDT-2.06%$10.48 AMN-0.84%$34.26 USPH-0.73%$82.47 ASTH+0.17%$34.36

Snapshot

Index	-	P/E	8.26	EPS (ttm)	25.28	Insider Own	-	Shs Outstand	6.88M	Perf Week	4.27%

Market Cap	1.44B	Forward P/E	7.49	EPS next Y	27.87	Insider Trans	-0.00%	Shs Float	3.40M	Perf Month	9.53%

Enterprise Value	1.57B	PEG	-	EPS next Q	5.71	Inst Own	-	Short Float	34.17%	Perf Quarter	38.72%

Income	180.00M	P/S	1.70	EPS this Y	9.94%	Inst Trans	-	Short Ratio	8.23	Perf Half Y	120.57%

Sales	847.00M	P/B	2.83	EPS next Y	0.28%	ROA	18.65%	Short Interest	1.16M	Perf YTD	26.83%

Book/sh	73.68	P/C	7.01	EPS next 5Y	-4.52%	ROE	51.88%	52W High	224.29 -6.91%	Perf Year	132.04%

Cash/sh	29.79	P/FCF	5.03	EPS past 3/5Y	- -15.75%	ROIC	33.39%	52W Low	83.99 148.59%	Perf 3Y	553.08%

Dividend Est.	-	EV/EBITDA	4.09	Sales past 3/5Y	58.68% 26.14%	Gross Margin	51.26%	Volatility	5.87% 5.20%	Perf 5Y	-

Dividend TTM	-	EV/Sales	1.85	EPS Y/Y TTM	160.35%	Oper. Margin	43.02%	ATR (14)	10.98	Perf 10Y	-

Dividend Ex-Date	-	Quick Ratio	4.96	Sales Y/Y TTM	76.46%	Profit Margin	21.25%	RSI (14)	60.87	Recom	2.00

Dividend Gr. 3/5Y	-	Current Ratio	5.00	EPS Q/Q	266.41%	SMA20	5.55%	Beta	2.02	Target Price	310.00

Payout	28.91%	Debt/Eq	0.81	Sales Q/Q	-13.52%	SMA50	16.39%	Rel Volume	1.65	Prev Close	214.32

Employees	1,037	LT Debt/Eq	0.78	Earnings	Nov 17	SMA200	44.06%	Avg Volume	149.84K	Price	208.79

IPO Date	Apr 04, 2022	Option/Short	No / Yes	EPS/Sales Surpr.	89.34% -1.99%	Net Debt/EBITDA	0.37	Volume	246,698	Change	-2.58%

Analyst Ratings

Date	Action	Analyst	Rating	Target
Aug-11-26	Reiterated	Lake Street	Buy	$235 → $310
Jun-02-26	Initiated	Lake Street	Buy	$235
Aug-26-25	Reiterated	Maxim Group	Buy	$45 → $205
Sep-18-24	Reiterated	Maxim Group		$45

Latest News· Times ET

Sep-18-26

Sep-18-2604:05AM

Nutex Health Q2 2026 Earnings Call: Complete TranscriptBenzinga

Sep-17-26

Sep-17-2606:05AM

5 Stocks With Recent Price Strength Amid a Volatile Septemberzacks.com

Sep-14-26

Sep-14-2612:46AM

Nutex Health Inc. (NASDAQ:NUTX) Given Average Recommendation of “Buy” by Brokeragesdefenseworld.net

Sep-11-26

Sep-11-2610:28AM

Stock Market Leaders Often Shine, Helped By This Sign Of Liquidity StrengthYahoo

05:55AM

What Makes Nutex Health (NUTX) a Good Fit for 'Trend Investing'zacks.com

Sep-10-26

Sep-10-2603:00PM

NUTEX HEALTH PROVIDES UPDATE REGARDING CYBERSECURITY EVENTprnewswire.com

Sep-04-26

Sep-04-2609:34AM

B. Riley Securities Maintains Buy on Nutex Health, Raises Price Target to $325Benzinga

Sep-01-26

Sep-01-2605:56PM

Nutex Health Data Breach: Edelson Lechtzin LLP Investigates Theft of Patient and Employee Dataprnewswire.com

01:00AM

AI Exhaustion? 3 Healthcare Stocks With 38% EPS Growth That Could Be The CureSeekingAlpha

Aug-31-26

Aug-31-2609:01AM

Nutex Health Inc. (NUTX) is a Great Momentum Stock: Should You Buy?zacks.com

01:30AM

Nutex Health Hospitals Earn Multiple Community Honors in Second Quarter 2026prnewswire.com

Aug-27-26

Aug-27-2607:05AM

4 Stocks With Solid Net Profit Margins to Boost Portfolio Returnszacks.com

Aug-26-26

Aug-26-2605:56AM

Here's Why 'Trend' Investors Would Love Betting on Nutex Health (NUTX)zacks.com

Aug-25-26

Aug-25-2609:21AM

Surging Earnings Estimates Signal Upside for Nutex Health (NUTX) Stockzacks.com

06:56AM

Wall Street Analysts See a 47.12% Upside in Nutex Health (NUTX): Can the Stock Really Move This High?zacks.com

Company

Nutex Health, Inc. functions as a technology-powered enterprise delivering healthcare services, structured into two key segments: its Hospital division and its Population Health Management division. The Hospital division is tasked with developing and overseeing various healthcare models, encompassing micro-hospitals, specialized medical centers, and hospital outpatient facilities. This segment currently owns and operates 21 locations spanning eight different states. Meanwhile, the Population Health Management division establishes and manages provider networks, such as independent physician associations. Additionally, its management services organizations furnish administrative, operational, and support assistance to its associated hospitals and physician groups. A proprietary, cloud-based technology platform within this division is crucial; it aggregates patient and provider data from multiple information systems, settings, and sources to construct a holistic view, thereby enabling more effective care delivery. The company maintains its corporate headquarters in Houston, Texas.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements

DataTimeframe

Line Item (USD, M)	TTM —	FY 2025 12/31/2025	FY 2024 12/31/2024	FY 2023 12/31/2023	FY 2022 12/31/2022	FY 2021 12/31/2021	FY 2020 12/31/2020	FY 2019 12/31/2019	FY 2018 12/31/2018
Total Revenue	847	875	480	—	—	—	—	—	—
Cost of Goods Sold Incl. D&A	413	431	284	—	—	—	—	—	—
Gross Profit	434	444	196	—	—	—	—	—	—
Selling, General and Administrative Excl. Other	63	169	59	—	—	—	—	—	—
Research and Development	0	0	0	—	—	—	—	—	—
Other Operating Expense	7	0	7	—	—	—	—	—	—
Operating Income	364	276	131	—	—	—	—	—	—
Interest Expense	20	22	20	—	—	—	—	—	—
Unusual Expense	—	—	—	—	—	—	—	—	—
Non-Operating Income (Expense)	-1	-9	-1	—	—	—	—	—	—
Net Income Before Taxes	344	245	110	—	—	—	—	—	—
Income Taxes	71	64	14	—	—	—	—	—	—
Consolidated Net Income	180	71	52	—	—	—	—	—	—
Net Income From Continuing Operations	273	180	95	—	—	—	—	—	—
Net Income	180	71	52	—	—	—	—	—	—
EPS (Recurring)	26.23	11.13	10.23	—	—	—	—	—	—
EPS (Basic, Before Extraordinaries)	26.23	11.13	10.23	—	—	—	—	—	—
EPS (Diluted)	25.28	10.48	9.71	—	—	—	—	—	—
EBITDA	384	288	149	—	—	—	—	—	—
Other After Tax Adjustments	—	—	—	—	—	—	—	—	—
Stock Option Compensation Expense	—	—	—	—	—	—	—	—	—
Price To Earnings Ratio	8.26	15.71	3.26	—	—	—	—	—	—
Price To Sales Ratio	1.73	1.13	0.33	—	—	—	—	—	—
Gross Margin	51.24	50.74	40.83	—	—	—	—	—	—
Operating Margin	42.98	31.54	27.29	—	—	—	—	—	—
Net Margin	21.25	8.11	10.83	—	—	—	—	—	—
Shares Outstanding	7	6	5	—	—	—	—	—	—
Market Capitalization	1,462	988	158	—	—	—	—	—	—
Operating Lease Expense	—	—	—	—	—	—	—	—	—

Unlock full historical data

See years of past statements with Premium.

Unlock with Premium

Insider Trading Volume

Insider Trading

Insider	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Saunders Scott J	Director	Sep 18 '26	Sale	214.25	203	43,493	400	Sep 18
Saunders Scott J	Director	Jul 31 '26	Option Exercise	0.00	603	0	603	Aug 03
Reed Michael Lee	Director	Jul 31 '26	Option Exercise	0.00	603	0	670	Aug 03
Grenas Cheryl Yvonne	Director	Jul 31 '26	Option Exercise	0.00	603	0	670	Aug 03
Jaumot Frank E	Director	Jul 31 '26	Option Exercise	0.00	603	0	753	Aug 03
Vo Thomas T.	Chief Executive Officer	Mar 10 '26	Option Exercise	0.00	18,016	0	1,846,213	Apr 10
Bamburg Wesley Shane	Chief Operating Officer	Mar 11 '26	Option Exercise	0.00	2,411	0	2,411	Mar 24
Jaumot Frank E	Director	Mar 20 '26	Buy	93.56	150	14,033	150	Mar 23
Hosseinion Warren	President	Mar 19 '26	Buy	94.07	252	23,706	7,765	Mar 23
Hosseinion Warren	President	Mar 10 '26	Option Exercise	0.00	13,605	0	15,739	Mar 23
Spears Kelvin	Director	Mar 17 '26	Buy	94.46	10	945	32,137	Mar 18
Spears Kelvin	Director	Mar 10 '26	Option Exercise	0.00	415	0	32,209	Mar 18
Montgomery Pamela W.	Chief Legal Officer-Healthcare	Mar 13 '26	Buy	88.87	79	7,021	2,758	Mar 16
Montgomery Pamela W.	Chief Legal Officer-Healthcare	Mar 10 '26	Option Exercise	0.00	5,132	0	5,217	Mar 16
Bates Jon Christian	Chief Financial Officer	Mar 11 '26	Option Exercise	0.00	1,694	0	5,527	Mar 11

open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR

QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.